TD Asset Management
THRD

TD Asset Management’s Third Harmonic Bio THRD Stock Holding History

TD Asset Management’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-86,396
Closed -$889K – 1270
2024
Q4 		$889K Buy
86,396
+48,194
+126% +$600K ﹤0.01% 1128
2024
Q3 		$516K Buy
+38,202
New +$473K ﹤0.01% 1297
2023
Q1 		– Sell
-32,767
Closed -$141K – 1461
2022
Q4 		$141K Buy
+32,767
New +$548K ﹤0.01% 1405

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

TD Asset Management's THRD Position: Q1 2025 in Review

TD Asset Management sold out of Third Harmonic Bio (THRD) in Q1 2025, closing a stake of 86,396 shares — an estimated $889K sold.

TD Asset Management first reported a position in THRD in Q4 2022 and held it in 3 quarters. The position peaked at $889K in Q4 2024. 99 funds tracked by Wall St. Rank hold THRD as of Q1 2025.

  • TD Asset Management reported no remaining Third Harmonic Bio position as of Q1 2025 after selling out during the quarter.
  • TD Asset Management sold 86,396 Third Harmonic Bio shares in Q1 2025, an estimated $889K.
  • TD Asset Management first reported a position in Third Harmonic Bio in Q4 2022 and held it in 3 quarters.
  • TD Asset Management's Third Harmonic Bio position peaked at $889K in Q4 2024.
  • 99 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q1 2025.

Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.